Hemodynamic changes in neonates born to mothers with Graves’ disease

Purpose Cardiac insufficiency is a major morbidity in neonatal hyperthyroidism. It is important to assess the hemodynamics in neonates born to mothers with Graves’ disease (GD). This study prospectively evaluated the hemodynamic changes in neonates born to mothers with GD. Methods Overall, 80 newbor...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Endocrine 2021-04, Vol.72 (1), p.171-178
Hauptverfasser: Ishikawa, Takamichi, Uchiyama, Hiroki, Iwashima, Satoru, Baba, Toru, Ohishi, Akira, Iijima, Shigeo, Itoh, Hiroaki
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 178
container_issue 1
container_start_page 171
container_title Endocrine
container_volume 72
creator Ishikawa, Takamichi
Uchiyama, Hiroki
Iwashima, Satoru
Baba, Toru
Ohishi, Akira
Iijima, Shigeo
Itoh, Hiroaki
description Purpose Cardiac insufficiency is a major morbidity in neonatal hyperthyroidism. It is important to assess the hemodynamics in neonates born to mothers with Graves’ disease (GD). This study prospectively evaluated the hemodynamic changes in neonates born to mothers with GD. Methods Overall, 80 newborns were enrolled. Thirty-six neonates were born to mothers with GD who were positive for thyroid-stimulating hormone (TSH) receptor antibody (TRAb), and 44 were born to mother negative for TRAb. The serum levels of TSH, free triiodothyronine (FT 3 ), free thyroxine (FT 4 ), and N-terminal-pro-B-type natriuretic peptide (NT-proBNP), the cardiac output, and cardiac index (CI) evaluated by echocardiography were compared between the two groups at several postnatal points (day of delivery and 5, 10, and 30 days of life). Results The TRAb-positive newborns had higher FT 4 levels and CI on Day 5 (both p  
doi_str_mv 10.1007/s12020-020-02443-w
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2434059659</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2434059659</sourcerecordid><originalsourceid>FETCH-LOGICAL-c370t-1b30e0455c9410df8758898f2677a3e678f6ac79ab33d29665d986c6058a15a03</originalsourceid><addsrcrecordid>eNp9kM9KAzEQxoMotv55AQ8S8OJldTbZ7CZHKbYVCl4UvIXsbtZu6W5qsrX05mv4ej6JI1sVPAgZMjDffPPxI-QshqsYILsOMQMGUV9JwqPNHhnGQqgIcL6PPRciApBPA3IUwgKAMZZmh2TAWSaFVHJIxlPbuHLbmqYuaDE37bMNtG5pa11rOuxz51vaOdq4bm59oJu6m9OJN682fLy907IO1gR7Qg4qswz2dPcfk8fx7cNoGs3uJ3ejm1lU8Ay6KM45WEiEKFQSQ1nJTEiMUWGqzHCbZrJKTZEpk3NeMpWmolQyLVIQ0sTCAD8ml73vyruXtQ2dbupQ2OXSYOB10CzhCQiVCoXSiz_ShVv7FtNpJhAcPs5QxXpV4V0I3lZ65evG-K2OQX9R1j1l3RdS1htcOt9Zr_PGlj8r31hRwHtBwBEi9b-3_7H9BFmyhv4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2520220232</pqid></control><display><type>article</type><title>Hemodynamic changes in neonates born to mothers with Graves’ disease</title><source>SpringerLink Journals</source><creator>Ishikawa, Takamichi ; Uchiyama, Hiroki ; Iwashima, Satoru ; Baba, Toru ; Ohishi, Akira ; Iijima, Shigeo ; Itoh, Hiroaki</creator><creatorcontrib>Ishikawa, Takamichi ; Uchiyama, Hiroki ; Iwashima, Satoru ; Baba, Toru ; Ohishi, Akira ; Iijima, Shigeo ; Itoh, Hiroaki</creatorcontrib><description>Purpose Cardiac insufficiency is a major morbidity in neonatal hyperthyroidism. It is important to assess the hemodynamics in neonates born to mothers with Graves’ disease (GD). This study prospectively evaluated the hemodynamic changes in neonates born to mothers with GD. Methods Overall, 80 newborns were enrolled. Thirty-six neonates were born to mothers with GD who were positive for thyroid-stimulating hormone (TSH) receptor antibody (TRAb), and 44 were born to mother negative for TRAb. The serum levels of TSH, free triiodothyronine (FT 3 ), free thyroxine (FT 4 ), and N-terminal-pro-B-type natriuretic peptide (NT-proBNP), the cardiac output, and cardiac index (CI) evaluated by echocardiography were compared between the two groups at several postnatal points (day of delivery and 5, 10, and 30 days of life). Results The TRAb-positive newborns had higher FT 4 levels and CI on Day 5 (both p  &lt; 0.05) and higher FT 3 ( p  &lt; 0.05) and FT 4 levels ( p  &lt; 0.01) and CI ( p  &lt; 0.01) but lower TSH levels ( p  &lt; 0.05) on Day 10 than the TRAb-negative newborns. The TRAb-positive newborns had significantly higher NT-proBNP levels on Days 5 (median 752 vs. 563 pg/mL, p  = 0.034) and 10 (median 789 vs. 552 pg/mL, p  = 0.002) than the TRAb-negative newborns. Conclusions Hemodynamic changes in neonates born to TRAb-positive mothers with GD resulted in a higher CI and NT-proBNP levels than in those with TRAb-negative mothers from postnatal days 5 to 10.</description><identifier>ISSN: 1355-008X</identifier><identifier>EISSN: 1559-0100</identifier><identifier>DOI: 10.1007/s12020-020-02443-w</identifier><identifier>PMID: 32785898</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Brain natriuretic peptide ; Coronary artery disease ; Diabetes ; Echocardiography ; Endocrinology ; Graves' disease ; Heart diseases ; Hemodynamics ; Humanities and Social Sciences ; Hyperthyroidism ; Internal Medicine ; Medicine ; Medicine &amp; Public Health ; Morbidity ; Mothers ; multidisciplinary ; Neonates ; Original Article ; Science ; Serum levels ; Thyroid hormones ; Thyroid-stimulating hormone ; Thyroxine ; Triiodothyronine</subject><ispartof>Endocrine, 2021-04, Vol.72 (1), p.171-178</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2020</rights><rights>Springer Science+Business Media, LLC, part of Springer Nature 2020.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c370t-1b30e0455c9410df8758898f2677a3e678f6ac79ab33d29665d986c6058a15a03</cites><orcidid>0000-0002-7118-3014</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12020-020-02443-w$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12020-020-02443-w$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32785898$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ishikawa, Takamichi</creatorcontrib><creatorcontrib>Uchiyama, Hiroki</creatorcontrib><creatorcontrib>Iwashima, Satoru</creatorcontrib><creatorcontrib>Baba, Toru</creatorcontrib><creatorcontrib>Ohishi, Akira</creatorcontrib><creatorcontrib>Iijima, Shigeo</creatorcontrib><creatorcontrib>Itoh, Hiroaki</creatorcontrib><title>Hemodynamic changes in neonates born to mothers with Graves’ disease</title><title>Endocrine</title><addtitle>Endocrine</addtitle><addtitle>Endocrine</addtitle><description>Purpose Cardiac insufficiency is a major morbidity in neonatal hyperthyroidism. It is important to assess the hemodynamics in neonates born to mothers with Graves’ disease (GD). This study prospectively evaluated the hemodynamic changes in neonates born to mothers with GD. Methods Overall, 80 newborns were enrolled. Thirty-six neonates were born to mothers with GD who were positive for thyroid-stimulating hormone (TSH) receptor antibody (TRAb), and 44 were born to mother negative for TRAb. The serum levels of TSH, free triiodothyronine (FT 3 ), free thyroxine (FT 4 ), and N-terminal-pro-B-type natriuretic peptide (NT-proBNP), the cardiac output, and cardiac index (CI) evaluated by echocardiography were compared between the two groups at several postnatal points (day of delivery and 5, 10, and 30 days of life). Results The TRAb-positive newborns had higher FT 4 levels and CI on Day 5 (both p  &lt; 0.05) and higher FT 3 ( p  &lt; 0.05) and FT 4 levels ( p  &lt; 0.01) and CI ( p  &lt; 0.01) but lower TSH levels ( p  &lt; 0.05) on Day 10 than the TRAb-negative newborns. The TRAb-positive newborns had significantly higher NT-proBNP levels on Days 5 (median 752 vs. 563 pg/mL, p  = 0.034) and 10 (median 789 vs. 552 pg/mL, p  = 0.002) than the TRAb-negative newborns. Conclusions Hemodynamic changes in neonates born to TRAb-positive mothers with GD resulted in a higher CI and NT-proBNP levels than in those with TRAb-negative mothers from postnatal days 5 to 10.</description><subject>Brain natriuretic peptide</subject><subject>Coronary artery disease</subject><subject>Diabetes</subject><subject>Echocardiography</subject><subject>Endocrinology</subject><subject>Graves' disease</subject><subject>Heart diseases</subject><subject>Hemodynamics</subject><subject>Humanities and Social Sciences</subject><subject>Hyperthyroidism</subject><subject>Internal Medicine</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Morbidity</subject><subject>Mothers</subject><subject>multidisciplinary</subject><subject>Neonates</subject><subject>Original Article</subject><subject>Science</subject><subject>Serum levels</subject><subject>Thyroid hormones</subject><subject>Thyroid-stimulating hormone</subject><subject>Thyroxine</subject><subject>Triiodothyronine</subject><issn>1355-008X</issn><issn>1559-0100</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kM9KAzEQxoMotv55AQ8S8OJldTbZ7CZHKbYVCl4UvIXsbtZu6W5qsrX05mv4ej6JI1sVPAgZMjDffPPxI-QshqsYILsOMQMGUV9JwqPNHhnGQqgIcL6PPRciApBPA3IUwgKAMZZmh2TAWSaFVHJIxlPbuHLbmqYuaDE37bMNtG5pa11rOuxz51vaOdq4bm59oJu6m9OJN682fLy907IO1gR7Qg4qswz2dPcfk8fx7cNoGs3uJ3ejm1lU8Ay6KM45WEiEKFQSQ1nJTEiMUWGqzHCbZrJKTZEpk3NeMpWmolQyLVIQ0sTCAD8ml73vyruXtQ2dbupQ2OXSYOB10CzhCQiVCoXSiz_ShVv7FtNpJhAcPs5QxXpV4V0I3lZ65evG-K2OQX9R1j1l3RdS1htcOt9Zr_PGlj8r31hRwHtBwBEi9b-3_7H9BFmyhv4</recordid><startdate>20210401</startdate><enddate>20210401</enddate><creator>Ishikawa, Takamichi</creator><creator>Uchiyama, Hiroki</creator><creator>Iwashima, Satoru</creator><creator>Baba, Toru</creator><creator>Ohishi, Akira</creator><creator>Iijima, Shigeo</creator><creator>Itoh, Hiroaki</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7118-3014</orcidid></search><sort><creationdate>20210401</creationdate><title>Hemodynamic changes in neonates born to mothers with Graves’ disease</title><author>Ishikawa, Takamichi ; Uchiyama, Hiroki ; Iwashima, Satoru ; Baba, Toru ; Ohishi, Akira ; Iijima, Shigeo ; Itoh, Hiroaki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c370t-1b30e0455c9410df8758898f2677a3e678f6ac79ab33d29665d986c6058a15a03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Brain natriuretic peptide</topic><topic>Coronary artery disease</topic><topic>Diabetes</topic><topic>Echocardiography</topic><topic>Endocrinology</topic><topic>Graves' disease</topic><topic>Heart diseases</topic><topic>Hemodynamics</topic><topic>Humanities and Social Sciences</topic><topic>Hyperthyroidism</topic><topic>Internal Medicine</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Morbidity</topic><topic>Mothers</topic><topic>multidisciplinary</topic><topic>Neonates</topic><topic>Original Article</topic><topic>Science</topic><topic>Serum levels</topic><topic>Thyroid hormones</topic><topic>Thyroid-stimulating hormone</topic><topic>Thyroxine</topic><topic>Triiodothyronine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ishikawa, Takamichi</creatorcontrib><creatorcontrib>Uchiyama, Hiroki</creatorcontrib><creatorcontrib>Iwashima, Satoru</creatorcontrib><creatorcontrib>Baba, Toru</creatorcontrib><creatorcontrib>Ohishi, Akira</creatorcontrib><creatorcontrib>Iijima, Shigeo</creatorcontrib><creatorcontrib>Itoh, Hiroaki</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Endocrine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ishikawa, Takamichi</au><au>Uchiyama, Hiroki</au><au>Iwashima, Satoru</au><au>Baba, Toru</au><au>Ohishi, Akira</au><au>Iijima, Shigeo</au><au>Itoh, Hiroaki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hemodynamic changes in neonates born to mothers with Graves’ disease</atitle><jtitle>Endocrine</jtitle><stitle>Endocrine</stitle><addtitle>Endocrine</addtitle><date>2021-04-01</date><risdate>2021</risdate><volume>72</volume><issue>1</issue><spage>171</spage><epage>178</epage><pages>171-178</pages><issn>1355-008X</issn><eissn>1559-0100</eissn><abstract>Purpose Cardiac insufficiency is a major morbidity in neonatal hyperthyroidism. It is important to assess the hemodynamics in neonates born to mothers with Graves’ disease (GD). This study prospectively evaluated the hemodynamic changes in neonates born to mothers with GD. Methods Overall, 80 newborns were enrolled. Thirty-six neonates were born to mothers with GD who were positive for thyroid-stimulating hormone (TSH) receptor antibody (TRAb), and 44 were born to mother negative for TRAb. The serum levels of TSH, free triiodothyronine (FT 3 ), free thyroxine (FT 4 ), and N-terminal-pro-B-type natriuretic peptide (NT-proBNP), the cardiac output, and cardiac index (CI) evaluated by echocardiography were compared between the two groups at several postnatal points (day of delivery and 5, 10, and 30 days of life). Results The TRAb-positive newborns had higher FT 4 levels and CI on Day 5 (both p  &lt; 0.05) and higher FT 3 ( p  &lt; 0.05) and FT 4 levels ( p  &lt; 0.01) and CI ( p  &lt; 0.01) but lower TSH levels ( p  &lt; 0.05) on Day 10 than the TRAb-negative newborns. The TRAb-positive newborns had significantly higher NT-proBNP levels on Days 5 (median 752 vs. 563 pg/mL, p  = 0.034) and 10 (median 789 vs. 552 pg/mL, p  = 0.002) than the TRAb-negative newborns. Conclusions Hemodynamic changes in neonates born to TRAb-positive mothers with GD resulted in a higher CI and NT-proBNP levels than in those with TRAb-negative mothers from postnatal days 5 to 10.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>32785898</pmid><doi>10.1007/s12020-020-02443-w</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-7118-3014</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1355-008X
ispartof Endocrine, 2021-04, Vol.72 (1), p.171-178
issn 1355-008X
1559-0100
language eng
recordid cdi_proquest_miscellaneous_2434059659
source SpringerLink Journals
subjects Brain natriuretic peptide
Coronary artery disease
Diabetes
Echocardiography
Endocrinology
Graves' disease
Heart diseases
Hemodynamics
Humanities and Social Sciences
Hyperthyroidism
Internal Medicine
Medicine
Medicine & Public Health
Morbidity
Mothers
multidisciplinary
Neonates
Original Article
Science
Serum levels
Thyroid hormones
Thyroid-stimulating hormone
Thyroxine
Triiodothyronine
title Hemodynamic changes in neonates born to mothers with Graves’ disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T02%3A45%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hemodynamic%20changes%20in%20neonates%20born%20to%20mothers%20with%20Graves%E2%80%99%20disease&rft.jtitle=Endocrine&rft.au=Ishikawa,%20Takamichi&rft.date=2021-04-01&rft.volume=72&rft.issue=1&rft.spage=171&rft.epage=178&rft.pages=171-178&rft.issn=1355-008X&rft.eissn=1559-0100&rft_id=info:doi/10.1007/s12020-020-02443-w&rft_dat=%3Cproquest_cross%3E2434059659%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2520220232&rft_id=info:pmid/32785898&rfr_iscdi=true